Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.13 - $0.44 $8,337 - $28,218
-64,133 Reduced 30.41%
146,764 $49,000
Q4 2022

Feb 13, 2023

SELL
$0.13 - $0.2 $168 - $259
-1,295 Reduced 0.61%
210,897 $31,000
Q3 2022

Nov 14, 2022

SELL
$0.17 - $0.3 $341 - $602
-2,009 Reduced 0.94%
212,192 $36,000
Q2 2022

Aug 12, 2022

SELL
$0.24 - $0.91 $703 - $2,667
-2,931 Reduced 1.35%
214,201 $51,000
Q1 2022

May 12, 2022

SELL
$1.02 - $2.46 $1,248 - $3,011
-1,224 Reduced 0.56%
217,132 $226,000
Q4 2021

Feb 10, 2022

BUY
$2.06 - $4.05 $5,963 - $11,724
2,895 Added 1.34%
218,356 $465,000
Q3 2021

Nov 09, 2021

BUY
$3.18 - $5.08 $1,564 - $2,499
492 Added 0.23%
215,461 $726,000
Q2 2021

Aug 11, 2021

BUY
$3.83 - $6.31 $823,331 - $1.36 Million
214,969 New
214,969 $864,000

About Calyxt, Inc.


  • Ticker CLXT
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 46,792,100
  • Market Cap $913M
  • Description
  • Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...
More about CLXT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.